NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

11102	Companies
244105	Keywords
172192	Articles
131508	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 05/17/2026 at 16:15, 4 months 12 days ago

Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
Nanobiotix presents part 1 data from JNJ-1900 (NBTXR3) in lung cancer at ESTRO 2026, showing promising responses. JNJ-1900 is a novel oncology product activated by radiotherapy

NANOBIOTIX Lung Cancer JNJ-1900 Radioenhancer ESTRO 2026
BRIEF

published on 05/04/2026 at 23:34, 4 months 25 days ago

Nanobiotix modifies the protocol of its phase 3 cancer study

FDA Head And Neck Cancer NANOBIOTIX NANORAY-312 Modified Protocol
BRIEF

published on 05/04/2026 at 23:34, 4 months 25 days ago

Nanobiotix met à jour le protocole de son étude de phase 3 sur le cancer

Approbation De La FDA Étude De Phase 3 NANOBIOTIX JNJ-1900 Amendement Au Protocole
BRIEF

published on 05/04/2026 at 23:34, 4 months 25 days ago

Nanobiotix Updates Protocol for Phase 3 Cancer Study

FDA Approval Protocol Amendment Phase 3 Study NANOBIOTIX JNJ-1900
BRIEF

published on 05/04/2026 at 23:34, 4 months 25 days ago

Nanobiotix modifie le protocole de son étude de phase 3 sur le cancer

FDA NANOBIOTIX Protocole Modifié NANORAY-312 Cancer Tête Et Cou
PRESS RELEASE

published on 05/04/2026 at 23:29, 4 months 25 days ago

NANOBIOTIX ANNONCE UN AMENDEMENT DU PROTOCOLE DE L’ÉTUDE MONDIALE DE PHASE 3 SUR LE CANCER DE LA TÊTE ET DU COU
Nanobiotix annonce un amendement du protocole de l'\xe9tude mondiale de phase 3 sur le cancer de la t^ete et du cou, acclrant la voie d'enregistrement de JNJ-1900 (NBTXR3)

Oncologie Protocole Amendement NANOBIOTIX JNJ-1900
PRESS RELEASE

published on 05/04/2026 at 23:29, 4 months 25 days ago

Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study
Nanobiotix announces FDA acceptance of protocol amendment to NANORAY-312 study for head and neck cancer, potentially accelerating global registration pathway for JNJ-1900 (NBTXR3)

Head And Neck Cancer Protocol Amendment NANOBIOTIX NBTXR3 JNJ-1900
BRIEF

published on 04/20/2026 at 08:35, 5 months 10 days ago

Nanobiotix révèle une biodisponibilité accrue et une toxicité réduite dans une étude préclinique

NANOBIOTIX Étude Préclinique Biodisponibilité Technologie Nanoprimer Immunothérapie Par LNP
BRIEF

published on 04/20/2026 at 08:35, 5 months 10 days ago

Nanobiotix Reveals Enhanced Bioavailability and Reduced Toxicity in Preclinical Study

Preclinical Study Bioavailability NANOBIOTIX Nanoprimer Technology LNP Immunotherapy
PRESS RELEASE

published on 04/20/2026 at 08:30, 5 months 10 days ago

Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology
Nanobiotix presents new preclinical data at AACR 2026 showcasing Nanoprimer technology enhancing systemic bioavailability and reducing toxicity for LNP-delivered DNA immunotherapy

Preclinical Data NANOBIOTIX Nanoprimer Technology Systemic Bioavailability Toxicity Reduction

Accesswire

Published on 09/30/2026 at 14:07, 31 minutes ago

Worksport COR Energy System Now Available Through Amazon
Published on 09/30/2026 at 13:30, 1 hour 8 minutes ago

Nextech3D.ai Engages MZ Group to Lead Strategic Investor Relations Program
Published on 09/30/2026 at 13:00, 1 hour 38 minutes ago

Grid Metals Announces Maiden Cesium Resource at Falcon West; Establishes Lucy South Cesium Deposit as the World's Second Largest Cesium Resource in Active Development
Published on 09/30/2026 at 11:00, 3 hours 38 minutes ago

High Tide Resources Stakes More Ground at Labrador West Iron Project as Drilling Concludes for 2026
Published on 09/30/2026 at 08:00, 6 hours 38 minutes ago

Alpha Growth Management Opens Rep Office in Japan

View all ACCESSWIRE

EQS Group

Published on 09/30/2026 at 14:21, 17 minutes ago

Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program XS3187013423
Published on 09/30/2026 at 14:13, 24 minutes ago

Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program XS3184156761
Published on 09/30/2026 at 14:05, 33 minutes ago

Latvian Companies and Researchers Sign Defense Technology and Genomics Agreements as LIAA US Trade Mission Concludes
Published on 09/30/2026 at 14:05, 33 minutes ago

NAKIKI SE invites investors and media representatives to a conference on 2 October 2026
Published on 09/30/2026 at 14:00, 38 minutes ago

Mutares completes the acquisition of Synthomer a.s. from Synthomer plc to grow further the Chemicals & Materials segment

Les Echos

Published on 09/30/2026 at 12:14, 2 hours 24 minutes ago

Mise à disposition du rapport financier semestriel au 30 juin 2026
Published on 09/30/2026 at 12:00, 2 hours 38 minutes ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 09/30/2026 at 12:00, 2 hours 38 minutes ago

Capital increase through exercise of subscription rights
Published on 09/30/2026 at 08:45, 5 hours 53 minutes ago

Air Liquide invests over 170 million euros to support a semiconductor leader expanding manufacturing capabilities in Japan
Published on 09/30/2026 at 08:45, 5 hours 53 minutes ago

Air Liquide investit plus de 170 millions d’euros pour accompagner un leader des semi-conducteurs dans le développement de ses capacités de production au Japon

View all LES ECHOS COMFI WIRE